Severity and risk of COVID-19 in cancer patients: An evidence-based learning.

Sharma, Akanksha; Malviya, Rishabha; Kumar, Vinod; Gupta, Ramji; Awasthi, Rajendra

Sharma, Akanksha; Malviya, Rishabha; Kumar, Vinod; Gupta, Ramji; Awasthi, Rajendra.

Afiliação

Sharma A; Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Uttar Pradesh, India.
Malviya R; Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Uttar Pradesh, India.
Kumar V; B.S. College of Pharmacy, Fatehullapur, Uttar Pradesh, India.
Gupta R; Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Uttar Pradesh, India.
Awasthi R; Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India.

Dermatol Ther ; 33(5): e13778, 2020 09.

Article em En | MEDLINE | ID: mdl-32515033

Assuntos

COVID-19/etiologia; Neoplasias/complicações; SARS-CoV-2; Humanos; Neoplasias/imunologia; Neoplasias/terapia; Risco; Índice de Gravidade de Doença

Palavras-chave

COVID-19 virus; cancer; health care; malignancy; patient care

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 / Neoplasias Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Dermatol Ther Assunto da revista: DERMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Índia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google